IMMY
Imprimis Pharmaceuticals, Inc.NASDAQ
1d
5d
1m
6m
1y
5y
10y
Advanced Chart
  • Dec. 2, 2014, 9:43 AM
    • In a all-stock transaction, Imprimis Pharmaceuticals (IMMY) acquires South Coast Specialty Compounding. As part of the transaction, Park signs a license agreement allowing it to immediately begin making and dispensing Imprimis' ophthalmology and urology formulations in the 13 states where it is currently licensed, including CA, NV, OR and HI.
    • Park will generate almost $4M in top line revenue in 2014.
    • Imprimis acquired its first pharmacy, Pharmacy Creations, LLC, in April 2014.
    | Dec. 2, 2014, 9:43 AM